🚀 VC round data is live in beta, check it out!
NanoRepro Valuation Multiples
Discover revenue and EBITDA valuation multiples for NanoRepro and similar public comparables like Promimic, Diagnos, Inspira Technologies, CurveBeam AI and more.
NanoRepro Overview
About NanoRepro
NanoRepro AG is engaged in the development, manufacturing, and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use.
Founded
N/A
HQ
Employees
16
Website
Financials (LTM)
EV
$13M
NanoRepro Financials
NanoRepro reported last 12-month revenue of $19M and negative EBITDA of ($2M).
In the same LTM period, NanoRepro generated ($2M) in EBITDA losses and had net loss of ($2M).
Revenue (LTM)
NanoRepro P&L
In the most recent fiscal year, NanoRepro reported revenue of $5M and EBITDA of ($4M).
NanoRepro expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $19M | XXX | $5M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $3M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 63% | XXX | XXX | XXX |
| EBITDA | ($2M) | XXX | ($4M) | XXX | XXX | XXX |
| EBITDA Margin | (9%) | XXX | (74%) | XXX | XXX | XXX |
| EBIT Margin | (12%) | XXX | (74%) | XXX | XXX | XXX |
| Net Profit | ($2M) | XXX | ($2M) | XXX | XXX | XXX |
| Net Margin | (9%) | XXX | (44%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
NanoRepro Stock Performance
NanoRepro has current market cap of $22M, and enterprise value of $13M.
Market Cap Evolution
NanoRepro's stock price is $1.73.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13M | $22M | 0.0% | XXX | XXX | XXX | $-0.19 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNanoRepro Valuation Multiples
NanoRepro trades at 0.7x EV/Revenue multiple, and (7.7x) EV/EBITDA.
EV / Revenue (LTM)
NanoRepro Financial Valuation Multiples
As of April 19, 2026, NanoRepro has market cap of $22M and EV of $13M.
Equity research analysts estimate NanoRepro's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
NanoRepro has a P/E ratio of (13.2x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $22M | XXX | $22M | XXX | XXX | XXX |
| EV (current) | $13M | XXX | $13M | XXX | XXX | XXX |
| EV/Revenue | 0.7x | XXX | 2.4x | XXX | XXX | XXX |
| EV/EBITDA | (7.7x) | XXX | (3.3x) | XXX | XXX | XXX |
| EV/EBIT | (5.9x) | XXX | (3.3x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.8x | XXX | XXX | XXX |
| P/E | (13.2x) | XXX | (9.1x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 1.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified NanoRepro Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
NanoRepro Margins & Growth Rates
NanoRepro's revenue in the last 12 month grew by 17%.
NanoRepro's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.5M for the same period.
NanoRepro's rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
NanoRepro's rule of X is 66% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
NanoRepro Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 17% | XXX | 218% | XXX | XXX | XXX |
| EBITDA Margin | (9%) | XXX | (74%) | XXX | XXX | XXX |
| EBITDA Growth | (124%) | XXX | (35%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 27% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 66% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 138% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
NanoRepro Public Comps
See public comps and valuation multiples for other Medical Devices and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| NanoRepro | XXX | XXX | XXX | XXX | XXX | XXX |
| Promimic | XXX | XXX | XXX | XXX | XXX | XXX |
| Diagnos | XXX | XXX | XXX | XXX | XXX | XXX |
| Inspira Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| EBM Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
NanoRepro M&A Activity
NanoRepro acquired XXX companies to date.
Last acquisition by NanoRepro was on XXXXXXXX, XXXXX. NanoRepro acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by NanoRepro
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNanoRepro Investment Activity
NanoRepro invested in XXX companies to date.
NanoRepro made its latest investment on XXXXXXXX, XXXXX. NanoRepro invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by NanoRepro
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout NanoRepro
| Where is NanoRepro headquartered? | NanoRepro is headquartered in Germany. |
| How many employees does NanoRepro have? | As of today, NanoRepro has over 16 employees. |
| Is NanoRepro publicly listed? | Yes, NanoRepro is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of NanoRepro? | NanoRepro trades under NN6 ticker. |
| When did NanoRepro go public? | NanoRepro went public in 2008. |
| Who are competitors of NanoRepro? | NanoRepro main competitors are Promimic, Diagnos, Inspira Technologies, CurveBeam AI. |
| What is the current market cap of NanoRepro? | NanoRepro's current market cap is $22M. |
| What is the current revenue of NanoRepro? | NanoRepro's last 12 months revenue is $19M. |
| What is the current revenue growth of NanoRepro? | NanoRepro revenue growth (NTM/LTM) is 17%. |
| What is the current EV/Revenue multiple of NanoRepro? | Current revenue multiple of NanoRepro is 0.7x. |
| Is NanoRepro profitable? | No, NanoRepro is not profitable. |
| What is the current EBITDA of NanoRepro? | NanoRepro has negative EBITDA and is not profitable. |
| What is NanoRepro's EBITDA margin? | NanoRepro's last 12 months EBITDA margin is (9%). |
| What is the current EV/EBITDA multiple of NanoRepro? | Current EBITDA multiple of NanoRepro is (7.7x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.